VYTORIN Superior to Lipitor at Lowering LDL Cholesterol, New Trial Shows

Subclinical hypothyroidism (SH) refers to patients who own an elevated station of the hormone thyrotropin, also particular contained by place of thyroid invigorating hormone (TSH), and a standard level of the hormone thyroxine (T4). The roomy proportion of SH increase beside age, and be almost ten percent in women done the age of 70, and to quite a few size vilify in man, according to circumstance data in the article.

In a subgroup of high chance patients (CHD or CHD risk equivalent), imperative difference in LDL cholesterol reduction at these doses resulted in more patients concluding factor a occupation of less than 100 mg/dL with VYTORIN in place of compared to Lipitor; sensationally, 82 percent of high risk patients next to VYTORIN 10/20 mg (n=106) achieve a cholesterol belittle goal of less than 100 mg/dL as compared to simply 47 percent for patients on Lipitor 10 mg (n=106, p less than 0.001). High risk patients in the research with a goal of less than 100 mg/dL who be taking VYTORIN 10/20 mg enjoy a baseline LDL cholesterol of 166 mg/dL as compared to patients taking Lipitor 10 mg who had a baseline of 169 mg/dL.

Eurand expect to unbroken the encouragement program near closing moment of 2006 and will trail regulatory submission all for the goods thereafter.

BÂRRX Medical, Inc. progress management solution for Barrett's esophagus, a precancerous specification of the echelon of the esophagus (swallowing tube) cause via gastroesophageal reflux disease, or GERD. Its flagship article of trade, the HALO360 System, provide uniform and controlled psychiatric help out at a standardized insight, which can rearrangement Barrett's esophagus and allow the regrowth of regular cell. In the largest workroom conduct (AIM-II Trial), 70 percent of patients be Barrett's-free (at one year follow-up). The rules previously own in the clinical trials was cleared by the U.S. Food and Drug Administration in 2001 and has be commercially at your disposal since January 2005. Based in Sunnyvale, Calif., BÂRRX Medical, Inc. was found in 2000 and is privately-held.